These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 18198935)

  • 1. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.
    Prosser LA; O'Brien MA; Molinari NA; Hohman KH; Nichol KL; Messonnier ML; Lieu TA
    Pharmacoeconomics; 2008; 26(2):163-78. PubMed ID: 18198935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of adult vaccination in medical settings and pharmacies: an observational study.
    Singhal PK; Zhang D
    J Manag Care Spec Pharm; 2014 Sep; 20(9):930-6. PubMed ID: 25166292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the Effect of a National Pharmacy-Led Influenza Vaccination Voucher Program on Morbidity, Mortality, and Costs.
    Singh T; Taitel M; Loy D; Smith-Ray R
    J Manag Care Spec Pharm; 2020 Jan; 26(1):42-47. PubMed ID: 31880234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiologic and economic impact of pharmacies as vaccination locations during an influenza epidemic.
    Bartsch SM; Taitel MS; DePasse JV; Cox SN; Smith-Ray RL; Wedlock P; Singh TG; Carr S; Siegmund SS; Lee BY
    Vaccine; 2018 Nov; 36(46):7054-7063. PubMed ID: 30340884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
    Prosser LA; Lavelle TA; Fiore AE; Bridges CB; Reed C; Jain S; Dunham KM; Meltzer MI
    PLoS One; 2011; 6(7):e22308. PubMed ID: 21829456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
    Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
    JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population characteristics associated with pharmacy-based influenza vaccination in United States survey data.
    Inguva S; Sautter JM; Chun GJ; Patterson BJ; McGhan WF
    J Am Pharm Assoc (2003); 2017; 57(6):654-660. PubMed ID: 28830660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
    Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
    JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
    Nichol KL
    Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.
    Clements KM; Chancellor J; Nichol K; DeLong K; Thompson D
    Value Health; 2011; 14(6):800-11. PubMed ID: 21914499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
    PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old.
    Raj SM; Chughtai AA; Sharma A; Tan TC; MacIntyre CR
    Vaccine; 2019 Sep; 37(40):5979-5985. PubMed ID: 31473001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009.
    Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL
    PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Place of influenza vaccination among children--United States, 2010-11 through 2013-14 influenza seasons.
    Santibanez TA; Vogt TM; Zhai Y; McIntyre AF
    Vaccine; 2016 Mar; 34(10):1296-303. PubMed ID: 26850756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence.
    Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT
    Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
    Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
    Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral agents for influenza: a comparison of cost-effectiveness data.
    Lynd LD; Goeree R; O'Brien BJ
    Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.
    Gatwood J; Meltzer MI; Messonnier M; Ortega-Sanchez IR; Balkrishnan R; Prosser LA
    Drugs; 2012 Jan; 72(1):35-48. PubMed ID: 22191794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective.
    Morales A; Martinez MM; Tasset-Tisseau A; Rey E; Baron-Papillon F; Follet A
    Value Health; 2004; 7(4):433-41. PubMed ID: 15449635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.